Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2294

1.

Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P.

BMC Gastroenterol. 2009 Sep 25;9:72. doi: 10.1186/1471-230X-9-72.

2.

Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.

Rahimi-Dehkordi N, Nourijelyani K, Nasiri-Tousi M, Ghodssi-Ghassemabadi R, Azmoudeh-Ardalan F, Nedjat S.

Arch Iran Med. 2014 Feb;17(2):118-21. doi: 014172/AIM.007.

3.

Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?

Cuomo O, Perrella A, Arenga G.

Transplant Proc. 2008 Jul-Aug;40(6):1906-9. doi: 10.1016/j.transproceed.2008.05.072.

PMID:
18675085
4.

Model for end-stage liver disease (MELD) and allocation of donor livers.

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R; United Network for Organ Sharing Liver Disease Severity Score Committee.

Gastroenterology. 2003 Jan;124(1):91-6.

PMID:
12512033
5.

Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.

Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.

Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.

PMID:
22410024
6.

Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.

Castro RS, Deisanti D, Seva-Pereira T, Almeida JR, Yamanaka A, Boin IF, Soares EC.

Transplant Proc. 2010 Mar;42(2):412-6. doi: 10.1016/j.transproceed.2010.01.028.

PMID:
20304153
7.

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.

Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA Jr, Lobue A, Zurstrassen MP, Moraes JM Jr, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.

Transplant Proc. 2007 Oct;39(8):2511-3.

PMID:
17954160
8.

Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.

Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP.

Hepatology. 2004 Jan;39(1):230-8.

PMID:
14752842
9.

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA.

Hepatology. 2004 Oct;40(4):802-10.

PMID:
15382176
10.

Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?

Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.

Liver Int. 2004 Oct;24(5):465-70.

PMID:
15482344
11.

Is MELD really the definitive score for liver allocation?

Lladó L, Figueras J, Memba R, Xiol X, Baliellas C, Vázquez S, Ramos E, Torras J, Rafecas A, Fabregat J, Lama C, Jaurrieta E.

Liver Transpl. 2002 Sep;8(9):795-8.

12.
13.

Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?

Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA.

Transpl Int. 2006 Apr;19(4):275-81.

14.

A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation.

Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, Burroughs AK.

Liver Transpl. 2006 Jul;12(7):1049-61. Review.

15.

Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.

Ecochard M, Boillot O, Guillaud O, Roman S, Adham M, Mion F, Dumortier J.

Clin Transplant. 2011 Sep-Oct;25(5):755-65. doi: 10.1111/j.1399-0012.2010.01366.x. Epub 2010 Dec 16.

PMID:
21158918
16.

Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements.

Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER.

Am J Transplant. 2004 Nov;4(11):1798-804.

17.

Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation.

Brandão A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G.

Clin Transplant. 2008 Sep-Oct;22(5):651-6. doi: 10.1111/j.1399-0012.2008.00860.x. Epub 2008 Jun 28.

PMID:
18549449
18.

Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.

Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.

J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.

PMID:
19686416
19.

A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.

Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L.

Liver Transpl. 2007 Jun;13(6):857-66.

Supplemental Content

Support Center